PWP1
geneOn this page
Also known as IEF-SSP-9502
Summary
PWP1 (PWP1 homolog, endonuclein, HGNC:17015) is a protein-coding gene on chromosome 12q23.3, encoding Periodic tryptophan protein 1 homolog (Q13610). Chromatin-associated factor that regulates transcription. It is a selective cancer dependency (DepMap: 83.5% of cell lines).
The protein encoded by this gene contains several WD-40 repeats and is found mostly in the nucleus. The expression and localization of this protein are cell cycle dependent. Expression of this gene is upregulated in pancreatic adenocarcinoma. Three transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 11137 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 70 total
- Cancer dependency (DepMap): dependent in 83.5% of screened cell lines
- MANE Select transcript:
NM_007062
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17015 |
| Approved symbol | PWP1 |
| Name | PWP1 homolog, endonuclein |
| Location | 12q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | IEF-SSP-9502 |
| Ensembl gene | ENSG00000136045 |
| Ensembl biotype | protein_coding |
| OMIM | 620055 |
| Entrez | 11137 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 10 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000412830, ENST00000541166, ENST00000547120, ENST00000547995, ENST00000552760, ENST00000867450, ENST00000920793, ENST00000920794, ENST00000920795, ENST00000920796, ENST00000945394, ENST00000945395
RefSeq mRNA: 3 — MANE Select: NM_007062
NM_001317962, NM_001317963, NM_007062
CCDS: CCDS81735, CCDS9114
Canonical transcript exons
ENST00000412830 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000923100 | 107692814 | 107692899 |
| ENSE00000923103 | 107697467 | 107697597 |
| ENSE00000923104 | 107699373 | 107699434 |
| ENSE00000923105 | 107702935 | 107703031 |
| ENSE00000923106 | 107703685 | 107703746 |
| ENSE00000923107 | 107704636 | 107704747 |
| ENSE00000923108 | 107708926 | 107709016 |
| ENSE00000923109 | 107709111 | 107709232 |
| ENSE00000923110 | 107710405 | 107710510 |
| ENSE00002270920 | 107712111 | 107713162 |
| ENSE00002420342 | 107685799 | 107685971 |
| ENSE00003471987 | 107693000 | 107693096 |
| ENSE00003479325 | 107688448 | 107688506 |
| ENSE00003499155 | 107688615 | 107688802 |
| ENSE00003564677 | 107696474 | 107696584 |
Expression profiles
Bgee: expression breadth ubiquitous, 292 present calls, max score 99.86.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 57.9339 / max 553.9949, expressed in 1829 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127859 | 55.1330 | 1829 |
| 127860 | 1.8396 | 1127 |
| 127862 | 0.8354 | 464 |
| 127861 | 0.1259 | 31 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 99.86 | gold quality |
| oocyte | CL:0000023 | 98.74 | gold quality |
| nipple | UBERON:0002030 | 98.24 | gold quality |
| pylorus | UBERON:0001166 | 96.85 | gold quality |
| cardia of stomach | UBERON:0001162 | 96.29 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 96.00 | gold quality |
| renal medulla | UBERON:0000362 | 95.74 | gold quality |
| pericardium | UBERON:0002407 | 95.25 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.14 | gold quality |
| cortical plate | UBERON:0005343 | 95.06 | gold quality |
| mammalian vulva | UBERON:0000997 | 95.05 | gold quality |
| pons | UBERON:0000988 | 95.01 | gold quality |
| parietal pleura | UBERON:0002400 | 95.01 | gold quality |
| urethra | UBERON:0000057 | 94.99 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 94.95 | gold quality |
| tibia | UBERON:0000979 | 94.92 | gold quality |
| mammary duct | UBERON:0001765 | 94.89 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 94.86 | gold quality |
| pleura | UBERON:0000977 | 94.82 | gold quality |
| saphenous vein | UBERON:0007318 | 94.82 | gold quality |
| cauda epididymis | UBERON:0004360 | 94.78 | gold quality |
| visceral pleura | UBERON:0002401 | 94.76 | gold quality |
| ventral tegmental area | UBERON:0002691 | 94.64 | gold quality |
| adult organism | UBERON:0007023 | 94.47 | gold quality |
| penis | UBERON:0000989 | 94.39 | gold quality |
| entorhinal cortex | UBERON:0002728 | 94.37 | gold quality |
| cranial nerve II | UBERON:0000941 | 94.32 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 94.31 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 94.30 | gold quality |
| superior surface of tongue | UBERON:0007371 | 94.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.11 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ESR1
miRNA regulators (miRDB)
44 targeting PWP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-4697-3P | 99.89 | 67.09 | 1123 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-623 | 99.76 | 68.16 | 1170 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-6165 | 99.44 | 67.12 | 1389 |
| HSA-MIR-377-3P | 99.37 | 70.18 | 1905 |
| HSA-MIR-542-3P | 99.34 | 67.58 | 1270 |
| HSA-MIR-4312 | 99.34 | 67.30 | 511 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-4777-5P | 99.33 | 67.53 | 1148 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-6780B-3P | 99.13 | 67.18 | 622 |
| HSA-MIR-1-5P | 98.70 | 68.66 | 1017 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 83.5% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- Endonuclein interacts with several proteins indicating a broad function including signal transduction and chaperone activity (PMID:20028516)
- High PWP1 expression is associated with head and neck squamous cell carcinoma. (PMID:29065309)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pwp1 | ENSDARG00000015921 |
| mus_musculus | Pwp1 | ENSMUSG00000001785 |
| rattus_norvegicus | Pwp1 | ENSRNOG00000005350 |
| drosophila_melanogaster | nclb | FBGN0263510 |
| caenorhabditis_elegans | WBGENE00021316 |
Protein
Protein identifiers
Periodic tryptophan protein 1 homolog — Q13610 (reviewed: Q13610)
Alternative names: Keratinocyte protein IEF SSP 9502
All UniProt accessions (3): B4DJV5, Q13610, F8VZ56
UniProt curated annotations — full annotation on UniProt →
Function. Chromatin-associated factor that regulates transcription. Regulates Pol I-mediated rRNA biogenesis and, probably, Pol III-mediated transcription. Regulates the epigenetic status of rDNA.
Subunit / interactions. Associates with the RNA polymerase (Pol I) complex. Interacts with POLR1E.
Subcellular location. Nucleus. Nucleolus. Chromosome.
Tissue specificity. High levels seen in the placenta, skeletal muscle, kidney and pancreas while lower levels were seen in the heart, brain and lung.
Similarity. Belongs to the WD repeat PWP1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q13610-1 | 1 | yes |
| Q13610-2 | 2 |
RefSeq proteins (3): NP_001304891, NP_001304892, NP_008993* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR019775 | WD40_repeat_CS | Conserved_site |
| IPR020472 | WD40_PAC1 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR044285 | PWP1 | Family |
Pfam: PF00400
UniProt features (21 total): modified residue 8, repeat 7, splice variant 2, chain 1, sequence variant 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q13610-F1 | 81.45 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (8): 21, 50, 55, 57, 59, 86, 485, 494
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 228 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, MORF_MTA1, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP, GOBP_RIBOSOME_BIOGENESIS, GRUETZMANN_PANCREATIC_CANCER_DN, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GCM_NPM1, MORF_CDK2, MORF_HDAC2, GOBP_RRNA_TRANSCRIPTION, PUJANA_CHEK2_PCC_NETWORK, WEI_MYCN_TARGETS_WITH_E_BOX, GCM_PPP1CC, MORF_RAF1, GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION
GO Biological Process (8): DNA-templated transcription (GO:0006351), rRNA processing (GO:0006364), negative regulation of DNA-templated transcription (GO:0045892), positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838), positive regulation of stem cell differentiation (GO:2000738), chromatin organization (GO:0006325), regulation of DNA-templated transcription (GO:0006355), ribosome biogenesis (GO:0042254)
GO Molecular Function (3): histone chaperone activity (GO:0140713), histone H4K20me3 reader activity (GO:1990889), protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), chromosome (GO:0005694), nucleolus (GO:0005730), Golgi apparatus (GO:0005794)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 2 |
| intracellular membrane-bounded organelle | 2 |
| intracellular membraneless organelle | 2 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| ribosome biogenesis | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| nucleolar large rRNA transcription by RNA polymerase I | 1 |
| positive regulation of transcription by RNA polymerase I | 1 |
| regulation of transcription of nucleolar large rRNA by RNA polymerase I | 1 |
| positive regulation of cell differentiation | 1 |
| stem cell differentiation | 1 |
| regulation of stem cell differentiation | 1 |
| cellular component organization | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| ribonucleoprotein complex biogenesis | 1 |
| histone binding | 1 |
| protein carrier activity | 1 |
| histone H4 reader activity | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
Protein interactions and networks
STRING
2398 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PWP1 | EBNA1BP2 | Q99848 | 860 |
| PWP1 | TBL3 | Q12788 | 720 |
| PWP1 | PDCD11 | Q14690 | 709 |
| PWP1 | PWP2 | Q15269 | 678 |
| PWP1 | WDR12 | Q9GZL7 | 673 |
| PWP1 | NSA2 | O95478 | 663 |
| PWP1 | RPF2 | Q9H7B2 | 601 |
| PWP1 | WDR3 | Q9UNX4 | 598 |
| PWP1 | TYW1 | Q9NV66 | 575 |
| PWP1 | GNL2 | Q13823 | 562 |
| PWP1 | RRP15 | Q9Y3B9 | 558 |
| PWP1 | UTP6 | Q9NYH9 | 550 |
| PWP1 | RSL24D1 | Q9UHA3 | 503 |
| PWP1 | SDF2L1 | Q9HCN8 | 491 |
| PWP1 | BRIX1 | Q8TDN6 | 491 |
IntAct
103 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBL | NOP56 | psi-mi:“MI:0914”(association) | 0.800 |
| TUBG1 | TUBG1 | psi-mi:“MI:2364”(proximity) | 0.760 |
| PWP1 | ANK3 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL7A | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| EN1 | NFIB | psi-mi:“MI:2364”(proximity) | 0.470 |
| ESR2 | FBLL1 | psi-mi:“MI:0914”(association) | 0.460 |
| PWP1 | DAPK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| H3C1 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.410 |
| PWP1 | TNS2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PIK3R3 | PWP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HOXA3 | PWP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NFYA | PWP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| Srp72 | psi-mi:“MI:0914”(association) | 0.350 | |
| JUN | TPM3 | psi-mi:“MI:0914”(association) | 0.350 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| C9orf72 | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| Mecom | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CAND1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL1 | LGALS8 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL4A | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| NEDD8 | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
| COPS6 | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
| CUL3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
| RPL15 | PRMT5 | psi-mi:“MI:0914”(association) | 0.350 |
| PTPRR | TCP1 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPYL5 | CBX4 | psi-mi:“MI:0914”(association) | 0.350 |
| rep | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (500): PWP1 (Affinity Capture-MS), PWP1 (Affinity Capture-MS), PWP1 (Affinity Capture-MS), FBL (Co-fractionation), GTPBP4 (Co-fractionation), KIAA0020 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), PWP1 (Co-fractionation), TOP1 (Co-fractionation)
ESM2 similar proteins: A1L112, A4IHS2, A8NZM5, B2ZZS9, O00423, O80775, O95834, P93107, P97452, Q05BC3, Q0DYP5, Q13216, Q13610, Q13685, Q15269, Q1JQD2, Q2HJ56, Q32KQ2, Q32P44, Q3SZK1, Q4V8C3, Q562C2, Q58DT8, Q5BIM8, Q5F3K4, Q5R9T6, Q5RCG7, Q5RFQ3, Q5VU92, Q5XI13, Q5ZK69, Q6DRF9, Q6P6T4, Q6PFM9, Q7TNG5, Q7YR70, Q810D6, Q8BH57, Q8BHB4, Q8BU03
Diamond homologs: A1Z8D0, O17468, Q13610, Q2HJ56, Q54YD8, Q99LL5, Q9P775, P21304, Q5R1S9, A5GFN6, A7EZJ5, O13923, O13985, O14435, O35353, O93277, O94620, P29387, P54311, P62871, P62872, P62873, P62874, P78406, P79959, Q04199, Q13112, Q3MV14, Q3SWS8, Q4IBR4, Q4R6D2, Q5E9A4, Q5FVA9, Q5GIS3, Q5R5W8, Q5RF99, Q6PH57, Q6ZD63, Q7RZI0, Q7ZWF0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 138 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Constitutive Signaling by Aberrant PI3K in Cancer | 7 | 8.8× | 6e-03 |
| PIP3 activates AKT signaling | 9 | 6.0× | 6e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| peptidyl-tyrosine phosphorylation | 5 | 16.6× | 1e-03 |
| cell surface receptor protein tyrosine kinase signaling pathway | 10 | 13.7× | 2e-06 |
| regulation of autophagy | 5 | 9.5× | 9e-03 |
| neuron differentiation | 10 | 7.9× | 1e-04 |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 12 | 7.4× | 2e-05 |
| gene expression | 9 | 5.7× | 3e-03 |
| protein stabilization | 10 | 5.3× | 2e-03 |
| positive regulation of MAPK cascade | 8 | 5.1× | 9e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1809 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:107685972:G:GC | donor_loss | 1.0000 |
| 12:107685973:T:G | donor_loss | 1.0000 |
| 12:107688445:CA:C | acceptor_loss | 1.0000 |
| 12:107688446:A:AG | acceptor_gain | 1.0000 |
| 12:107688447:G:GA | acceptor_gain | 1.0000 |
| 12:107688447:GGT:G | acceptor_gain | 1.0000 |
| 12:107688447:GGTA:G | acceptor_gain | 1.0000 |
| 12:107688502:TTGCA:T | donor_gain | 1.0000 |
| 12:107688503:TGCA:T | donor_gain | 1.0000 |
| 12:107688504:GCA:G | donor_gain | 1.0000 |
| 12:107688504:GCAG:G | donor_gain | 1.0000 |
| 12:107688505:CA:C | donor_gain | 1.0000 |
| 12:107688506:AG:A | donor_loss | 1.0000 |
| 12:107688507:G:C | donor_loss | 1.0000 |
| 12:107688507:G:GG | donor_gain | 1.0000 |
| 12:107688508:TAA:T | donor_loss | 1.0000 |
| 12:107688604:T:A | acceptor_gain | 1.0000 |
| 12:107688606:T:TA | acceptor_gain | 1.0000 |
| 12:107688611:A:AG | acceptor_gain | 1.0000 |
| 12:107688612:T:G | acceptor_gain | 1.0000 |
| 12:107688613:A:AG | acceptor_gain | 1.0000 |
| 12:107688614:G:GC | acceptor_gain | 1.0000 |
| 12:107688614:GA:G | acceptor_gain | 1.0000 |
| 12:107688614:GAGA:G | acceptor_gain | 1.0000 |
| 12:107688614:GAGAA:G | acceptor_gain | 1.0000 |
| 12:107688738:G:GT | donor_gain | 1.0000 |
| 12:107688759:GGC:G | donor_gain | 1.0000 |
| 12:107688760:GC:G | donor_gain | 1.0000 |
| 12:107688761:C:G | donor_gain | 1.0000 |
| 12:107688765:G:GG | donor_gain | 1.0000 |
AlphaMissense
3322 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:107697479:C:A | A209D | 1.000 |
| 12:107699404:T:A | V259D | 1.000 |
| 12:107702948:A:C | S274R | 1.000 |
| 12:107702950:T:A | S274R | 1.000 |
| 12:107702950:T:G | S274R | 1.000 |
| 12:107702978:T:A | W284R | 1.000 |
| 12:107702978:T:C | W284R | 1.000 |
| 12:107704718:T:A | W350R | 1.000 |
| 12:107704718:T:C | W350R | 1.000 |
| 12:107709122:A:C | S394R | 1.000 |
| 12:107709124:C:A | S394R | 1.000 |
| 12:107709124:C:G | S394R | 1.000 |
| 12:107697511:T:A | W220R | 0.999 |
| 12:107697511:T:C | W220R | 0.999 |
| 12:107702946:C:A | A273E | 0.999 |
| 12:107702954:T:C | S276P | 0.999 |
| 12:107702960:G:C | D278H | 0.999 |
| 12:107702980:G:C | W284C | 0.999 |
| 12:107702980:G:T | W284C | 0.999 |
| 12:107703686:T:A | V302D | 0.999 |
| 12:107703700:T:C | F307L | 0.999 |
| 12:107703702:T:A | F307L | 0.999 |
| 12:107703702:T:G | F307L | 0.999 |
| 12:107703725:T:C | L315P | 0.999 |
| 12:107703734:G:A | G318D | 0.999 |
| 12:107708929:A:C | S361R | 0.999 |
| 12:107708931:T:A | S361R | 0.999 |
| 12:107708931:T:G | S361R | 0.999 |
| 12:107708942:G:A | G365D | 0.999 |
| 12:107708942:G:T | G365V | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000061216 (12:107689739 C>G), RS1000076371 (12:107693991 A>G), RS1000112495 (12:107711187 G>A), RS1000156109 (12:107701361 C>T), RS1000194906 (12:107710910 T>A,C), RS1000209346 (12:107701108 G>A), RS1000246255 (12:107695091 T>A), RS1000274163 (12:107695139 G>A), RS1000407001 (12:107695421 A>C), RS1000696119 (12:107684397 G>A,C,T), RS1000725161 (12:107684037 G>C), RS1000784263 (12:107687617 C>A,T), RS1000846879 (12:107691051 A>G), RS1000907280 (12:107706817 T>C), RS1001012369 (12:107697003 G>T)
Disease associations
OMIM: gene MIM:620055 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002481_2 | Acne (severe) | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 2 |
| sodium arsenite | decreases expression | 2 |
| Cyclosporine | decreases expression, increases expression | 2 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| geraniol | decreases expression | 1 |
| ochratoxin A | decreases acetylation, decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| chromium hexavalent ion | affects expression | 1 |
| bisphenol S | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Diethylstilbestrol | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Ivermectin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Potassium Dichromate | increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Selenium | affects cotreatment, decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Vitamin E | affects cotreatment, decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): acne